Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus
about
Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic DiseasesADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiographyEndogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients.Asymmetric dimethylarginine downregulates sarco/endoplasmic reticulum calcium‑ATPase 3 and induces endoplasmic reticulum stress in human umbilical vein endothelial cells.
P2860
Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@ast
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@en
type
label
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@ast
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@en
prefLabel
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@ast
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@en
P2093
P2860
P356
P1476
Asymmetric dimethylarginine, a ...... lications in diabetes mellitus
@en
P2093
Fumihiro Ochi
Hiroyuki Konya
Jun-Ichiro Miyagawa
Kahori Satani
Masaru Tokuda
Masayuki Miuchi
Mitsuyoshi Namba
Satoshi Matsutani
Takashi Ikawa
Taku Tsunoda
P2860
P304
P356
10.5493/WJEM.V5.I2.110
P577
2015-05-20T00:00:00Z